AGA welcomes our corporate partners to be members of our corporate roundtable.
The roundtable engages corporate magnates and AGA leadership in dialogue regarding innovations in practice, clinical and scientific advancements, policy, and other issues that impact the science and practice of gastroenterology and hepatology.
By harnessing the best minds in these areas, we can truly understand the state-of-the-science accomplishments that are being achieved and leverage them to better serve the gastroenterological community and improve care for patients.
Roundtable members at all levels are invited to participate in annual joint meetings. These meetings provide a unique opportunity for interaction within the GI community, enabling members to share information with each other and hear speakers address common topics of interest.
To join the roundtable, please contact Nancy Chill, vice president, corporate relations and business development.
2018-2019 AGA Corporate Roundtable
We thank the current roundtable members for their commitment.
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Genentech, Inc.
- McNeil Consumer Healthcare
- Pfizer, Inc.
- Salix Pharmaceuticals
- Takeda Pharmaceuticals U.S.A., Inc.
- UCB, Inc.
- Boston Scientific
- Ferring Pharmaceuticals Inc.
- Gilead Sciences, Inc.
- Ironwood Pharmaceuticals
- Janssen Biotech, Inc.
- PENTAX Medical
- Shionogi Inc.
As of Feb. 4, 2019.
Fees will support the AGA Research Foundation.
Please contact Nancy Chill, vice president, education and business development.